KYNB
Kyntra Bio, Inc.
NASDAQ: KYNB · HEALTHCARE · BIOTECHNOLOGY
$7.27
+3.12% today
Updated 2026-04-30
Market cap
$28.37M
P/E ratio
—
P/S ratio
4.41x
EPS (TTM)
$-14.40
Dividend yield
—
52W range
$5 – $13
Volume
0.0M
Kyntra Bio, Inc. (KYNB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.61M | $25.92M | $22.41M | $-18.57M | $7.11M | $-66.51M | $-76.14M | $-78.70M | $81.60M | $-82.23M | $-145.93M | $-315.02M | $-138.00M | $-4.77M |
| Capital expenditures | $744000.00 | $6.81M | $8.12M | $1.98M | $1.25M | $8.50M | $8.02M | $5.76M | $3.99M | $30.19M | $38.74M | $2.52M | $266000.00 | $38000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $4.56M | $3.44M | $18.70M | $27.68M | $32.13M | $37.54M | $52.14M | $66.27M | $72.72M | $71.16M | $65.60M | $50.77M | $25.21M | $6.58M |
| Free cash flow | $-6.35M | $19.11M | $14.30M | $-20.55M | $5.86M | $-75.01M | $-84.16M | $-84.47M | $77.61M | $-112.42M | $-184.67M | $-317.54M | $-138.26M | $-4.81M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | $2.23M | $3.95M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |